VAR2 Pharmaceuticals is attending the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Barcelona between 18-20 November 2026. Our Executive Chairman of the Board Mads Daugaard will be accompanied by our Deputy Chief Medical Officer Thomas Clausen at the event. VAR2 Pharmaceuticals will feature a Late-breaking Poster Presentation (poster no. PB-011, abstract no. […]